April 11, 2018 / 6:40 AM / 11 days ago

BRIEF-Guangdong Zhongsheng Pharmaceutical receives patent certificate from Israel patent office

April 11 (Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd

* Says it received patent certificate(NO. 247970) named QUINOLINE DERIVATIVES AS SMO INHIBITORS, from Israel patent office

* Patent valid for 20 years since March 16, 2015

Source text in Chinese:goo.gl/33KJwH

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below